As per our report, the size of the Veterinary Healthcare Market in the Asia Pacific is valued at a $5.98 billion market as of 2020 and is estimated to be a $10.82 billion market by 2025 with a tremendous CAGR of 12.6% in the review period.
Veterinary medicines help in diagnosing, treating and preventing diseases in animals. Veterinary medicine covers a wide range of animal species which includes both domestic and wild. With the increased production of livestock animals, there is a significant growth in the animal healthcare market. The stable economy and rising population, especially in developing countries has resulted in increased demand for protein-rich foods.
Growing awareness about animal’s health, fewer hurdles for the approval of drugs relating to animal health and increasing love towards pets are the primary contributing factors for the growth of veterinary healthcare. The rising number of foodborne diseases has also helped in the growth of the market.
However, factors like increasing regulation on antibodies, rising costs of animal testing are restraining the growth of the market.
This research report segmented and sub-segmented into the following categories:
Key Developments in the Market
Leading companies in the APAC Veterinary Healthcare Market profiled in this report are Merck & Co., Inc., Bayer AG, Boehringer Ingelheim GmbH, Cargill, Inc., Ceva Santé Animale, Novasep, Eli Lilly and Company, Koninklijke DSM N.V, Novartis AG, Nutreco N.V., Sanofi S.A., SeQuent Scientific Ltd., Virbac S.A., Vétoquinol S.A. and Zoetis Inc
This report helps you understand:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Pharmaceuticals
5.1.1.1 Vaccines
5.1.1.2 Antibiotics
5.1.1.3 Parasiticides
5.1.1.4 Others
5.1.2 Feed Additives
5.1.2.1 Medical Feed Additives
5.1.2.2 Nutritional Feed Additives
5.1.3 Y-o-Y Growth Analysis, By Product
5.1.4 Market Attractiveness Analysis, By Product
5.1.5 Market Share Analysis, By Product
5.2 Animal Type
5.2.1 Livestock Animals
5.2.1.1 Cattle
5.2.1.2 Swine
5.2.1.3 Sheep
5.2.1.4 Poultry
5.2.1.5 Aquatic
5.2.1.6 Others
5.2.2 Companion Animals
5.2.2.1 Dogs
5.2.2.2 Cats
5.2.3 Y-o-Y Growth Analysis, By Animal Type
5.2.4 Market Attractiveness Analysis, By Animal Type
5.2.5 Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Animal Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Animal Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Animal Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 MSD Animal Health
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer AG
8.3 Boehringer Ingelheim GmbH
8.4 Ceva Santé Animale
8.5 Eli Lilly and Company
8.6 Cargill, Inc
8.7 Novasep
8.8 Koninklijke DSM N.V
8.9 Nutreco N.V.
8.10 SeQuent Scientific Ltd.
8.11 Virbac S.A.
8.12 Vétoquinol S.A.
8.13 Zoetis Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
